Overview

Optimization of Therapeutic Human Serum Albumin Infusion in Selected Critically Ill Patients

Status:
Terminated
Trial end date:
2019-08-10
Target enrollment:
Participant gender:
Summary
Primary purpose : mortality at Day 28 Secondary purposes : - Daily SOFA (Sequential Organ Failure Assessment) score lessening within Intensive Care Unit (ICU) - Duration of increasing doses of norepinephrine infusion to maintain target mean arterial pressure - Number of care-related infections within ICU
Phase:
Phase 4
Details
Lead Sponsor:
University Hospital, Strasbourg, France
Treatments:
Norepinephrine